The High Rate of Lactose Intolerance is Anticipated to Fuel the Global Lactose Intolerance Treatment Market at a CAGR of 5.90% during the Forecast Period of 2022 to 2030

Pune, India, March 2022, MRFR Press Release/- Market Research Future has published a Cooked Research Report on the Global Lactose Intolerance Treatment Market.

Market Highlights

Global Lactose Intolerance Treatment Market is expected to register a CAGR of 5.90% during the assessment period of 2023 to 2030 to reach USD 26.12 Billion by 2030.

Lactose intolerance, also known as congenital alactasia reduces infants' ability to break-down lactose in breast milk or formula. The affected infants can experience severe weight loss or dehydration without the lactose intolerance treatment. The intolerance also affects adults with reduced production of lactase after infancy. The increasing prevalence of lactose intolerance worldwide globally is driving the market growth of this market.

Segment Analysis

Global Lactose Intolerance Treatment Market based on the type has been segmented into primary lactose intolerance, secondary lactose intolerance, congenital lactose intolerance. The global lactose intolerance treatment market, by treatment, has been segmented into food supplements, enzyme lactase supplements, probiotics. Based on form, the market is bifurcated into powder, liquid, and tablets. The global lactose intolerance treatment market, by end user, is bifurcated into homecare, hospitals & clinics, and others.

Regional Analysis

Global Lactose Intolerance Treatment Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa.

The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas accounted for the largest share in 2019 due to the rising number of patients opting for lactose intolerance treatment and technological advancement in the market.

The European lactose intolerance treatment market has been further segmented into Western Europe and Eastern Europe. The Western Europe market has further been classified into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. The increasing incidence of lactose intolerance in European countries and rising research and development activity, and new product launch and approval are expected to propel the lactose intolerance treatment market during the forecast period.

The market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is expected to register the highest growth rate over the forecast period from 2020 to 2027. Overall, the region has shown strong dairy product sales between the year 2012 to 2017. The growth driver of this region is the rise of modern trade, changing consumer habits, and dynamic product development.

The Middle East & Africa lactose intolerance treatment market is segmented into the Middle East and Africa. Increasing healthcare expenditure in the region is expected to fuel the market growth of the region.

Explore In-depth Details: Lactose Intolerance Treatment Market Research Report

Key Players

MRFR recognizes the following companies as the Key Players in the global Lactose Intolerance Treatment Market— Abbott (US)., Nestlé (Switzerland), Cargill, Incorporated (US), Dean Foods (US), and Johnson & Johnson Services, Inc (US).

Key Findings of the Study

• Global Lactose Intolerance Treatment Market is estimated to reach USD 26.12 Billion by 2030 at a CAGR of 5.90%during the assessment period of 2022 to 2030.


• The Americas accounted for the largest share of the global lactose intolerance treatment market due to the presence of prominent players in the US, high uptake rate, and increasing product clearances from regulatory authorities.


• Based on type, the primary lactose intolerance segment accounted for the largest market share of 71.9% in 2019.


• Based on treatment, the probiotics segment is the fastest-growing segment during the forecast period at a CAGR of 7.34%.


• Based on form, the market segmented into powder, liquid, tablet. The powder segment dominated the market with a CAGR of 5.76%.